Ameritas Investment Partners’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.02K Hold
4,493
﹤0.01% 2961
2025
Q4
$11K Hold
4,493
﹤0.01% 2885
2025
Q3
$30.1K Hold
4,493
﹤0.01% 2480
2025
Q2
$26.4K Hold
4,493
﹤0.01% 2537
2025
Q1
$37.7K Hold
4,493
﹤0.01% 2270
2024
Q4
$33.4K Hold
4,493
﹤0.01% 2409
2024
Q3
$26.1K Hold
4,493
﹤0.01% 2522
2024
Q2
$29.9K Hold
4,493
﹤0.01% 2428
2024
Q1
$58.6K Hold
4,493
﹤0.01% 2055
2023
Q4
$57.3K Hold
4,493
﹤0.01% 2092
2023
Q3
$58.9K Buy
4,493
+759
+20% +$13.9K ﹤0.01% 1995
2023
Q2
$95.5K Buy
3,734
+780
+26% +$20.1K ﹤0.01% 1628
2023
Q1
$74.4K Buy
2,954
+629
+27% +$14.8K ﹤0.01% 1727
2022
Q4
$60.8K Hold
2,325
﹤0.01% 1930
2022
Q3
$51K Hold
2,325
﹤0.01% 1966
2022
Q2
$33K Hold
2,325
﹤0.01% 2266
2022
Q1
$44K Hold
2,325
﹤0.01% 2134
2021
Q4
$43K Buy
2,325
+1,468
+171% +$30.3K ﹤0.01% 2223
2021
Q3
$23K Hold
857
﹤0.01% 2628
2021
Q2
$27K Buy
+857
New +$27.3K ﹤0.01% 2571

Other funds holding TMCI

Ameritas Investment Partners's TMCI Position: Q1 2026 in Review

Ameritas Investment Partners held its Treace Medical Concepts (TMCI) position steady in Q1 2026 at 4,493 shares worth $6.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.

Ameritas Investment Partners first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $95.5K in Q2 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Ameritas Investment Partners held 4,493 shares of Treace Medical Concepts worth $6.02K as of Q1 2026.
  • Ameritas Investment Partners left its Treace Medical Concepts share count unchanged in Q1 2026.
  • Treace Medical Concepts made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2961 holding.
  • Ameritas Investment Partners first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
  • Ameritas Investment Partners's Treace Medical Concepts position peaked at $95.5K in Q2 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.